NCT04462263View on ClinicalTrials.gov

Study to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

June 23, 2021

Study Completion Date

June 23, 2021

Conditions
Healthy
Interventions
DRUG

HTL0014242

Solid suspension capsule

Trial Locations (1)

HA1 3UJ

Parexel Early Phase Clinical Unit, Harrow

All Listed Sponsors
lead

Nxera Pharma UK Limited

INDUSTRY

NCT04462263 - Study to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects | Biotech Hunter | Biotech Hunter